Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF – Get Free Report) shares traded up 2.9% during mid-day trading on Monday . The stock traded as high as $9.36 and last traded at $9.36. 500 shares changed hands during trading, a decline of 17% from the average session volume of 600 shares. The stock had previously closed at $9.10.
Newron Pharmaceuticals Trading Up 2.9 %
The stock’s fifty day moving average price is $9.31 and its 200-day moving average price is $10.27.
Newron Pharmaceuticals Company Profile
Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea.
Read More
- Five stocks we like better than Newron Pharmaceuticals
- Following Congress Stock Trades
- Intel: Is Now the Time to Be Brave?Â
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Learn Technical Analysis Skills to Master the Stock Market
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Newron Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newron Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
